SCHEMBL2300923

SCHEMBL2300923

Cc1ccc(-c2ccccc2)nc1Cl

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.53
MEN1 O00255 5/20 0.48
KMT2A Q03164 5/20 0.48
RAB9A P51151 4/20 0.48
ALDH1A1 P00352 5/20 0.47
KDM4E B2RXH2 5/20 0.47
HPGD P15428 3/20 0.47
MAPT P10636 3/20 0.47
TDP1 Q9NUW8 1/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
LMNA P02545 2/20 0.44
PKM P14618 2/20 0.44
POLB P06746 1/20 0.44
NPC1 O15118 2/20 0.42
PDGFRB P09619 1/20 0.42
KDR P35968 1/20 0.42
FLT3 P36888 1/20 0.42
TP53 P04637 2/20 0.41
ADORA1 P30542 1/20 0.41
ASIC3 Q9UHC3 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13299549 0.78 ALDH1A1 (0.58) L3MBTL1MEN1KMT2ARAB9AALDH1A1
Ammonia Solution, Strong SCHEMBL28686928 0.77 ALDH1A1 (0.56) L3MBTL1MEN1KMT2ARAB9AALDH1A1
SCHEMBL10205828 0.77 ALDH1A1 (0.60) L3MBTL1MEN1KMT2ARAB9AALDH1A1
SCHEMBL12620535 0.76 ALDH1A1 (0.65) L3MBTL1MEN1KMT2ARAB9AALDH1A1
SCHEMBL13906450 0.76 CASP1 (0.42) LMNA
SCHEMBL10637497 0.75 ALDH1A1 (0.55) L3MBTL1MEN1KMT2ARAB9AALDH1A1
SCHEMBL23702940 0.75 MEN1 (0.48) L3MBTL1MEN1KMT2ARAB9AALDH1A1
SCHEMBL27810693 0.75 MAP2K3 (0.53) L3MBTL1MEN1KMT2ARAB9AALDH1A1
SCHEMBL28247990 0.75 ASIC3 (0.50) MEN1KMT2ARAB9AALDH1A1KDM4E
SCHEMBL24250307 0.75 MEN1 (0.48) L3MBTL1MEN1KMT2ARAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110195993-A1 PPAR AGONIST COMPOUNDS, PREPARATION AND USES GENFIT (FR) 2011-08-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110195993-A1 PPAR AGONIST COMPOUNDS, PREPARATION AND USES PPARD, PPARA, PPARG L3MBTL1 3993/4885MEN1 4851/4885KMT2A 3347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.